These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20435135)

  • 1. Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
    van der Burg B; Winter R; Weimer M; Berckmans P; Suzuki G; Gijsbers L; Jonas A; van der Linden S; Witters H; Aarts J; Legler J; Kopp-Schneider A; Bremer S
    Reprod Toxicol; 2010 Aug; 30(1):73-80. PubMed ID: 20435135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
    van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
    Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: results of test performance and transferability.
    Witters H; Freyberger A; Smits K; Vangenechten C; Lofink W; Weimer M; Bremer S; Ahr PH; Berckmans P
    Reprod Toxicol; 2010 Aug; 30(1):60-72. PubMed ID: 20362049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
    Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
    Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation.
    Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards an integrated in vitro strategy for estrogenicity testing.
    Wang S; Aarts JM; de Haan LH; Argyriou D; Peijnenburg AA; Rietjens IM; Bovee TF
    J Appl Toxicol; 2014 Sep; 34(9):1031-40. PubMed ID: 24114741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
    Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
    Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
    Freyberger A; Wilson V; Weimer M; Tan S; Tran HS; Ahr HJ
    Reprod Toxicol; 2010 Aug; 30(1):50-9. PubMed ID: 20074635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
    Rogers JM; Denison MS
    In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity.
    Soto AM; Maffini MV; Schaeberle CM; Sonnenschein C
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):15-33. PubMed ID: 16522517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Alkylphenols and related chemicals show similar effect on the function of human and rat estrogen receptor alpha in reporter gene assay.
    Sun H; Xu XL; Qu JH; Hong X; Wang YB; Xu LC; Wang XR
    Chemosphere; 2008 Mar; 71(3):582-8. PubMed ID: 18028983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of endocrine disrupting chemicals with MELN cells, an ER-transactivation assay combined with cytotoxicity assessment.
    Berckmans P; Leppens H; Vangenechten C; Witters H
    Toxicol In Vitro; 2007 Oct; 21(7):1262-7. PubMed ID: 17572059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
    Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
    Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
    Freyberger A; Schmuck G
    Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of estrogen and androgen activity of food contact materials by different in vitro bioassays (YES, YAS, ERα and AR CALUX) and chromatographic analysis (GC-MS, HPLC-MS).
    Mertl J; Kirchnawy C; Osorio V; Grininger A; Richter A; Bergmair J; Pyerin M; Washüttl M; Tacker M
    PLoS One; 2014; 9(7):e100952. PubMed ID: 25000404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters.
    Pillon A; Servant N; Vignon F; Balaguer P; Nicolas JC
    Anal Biochem; 2005 May; 340(2):295-302. PubMed ID: 15840503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
    Navas JM; Segner H
    Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.